Back to search

Article

The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML

2013-11-15

Abstract excerpt

Abstract Therapy-related acute myeloid leukemia (t-AML) and therapy-related myelodysplastic syndrome (t-MDS) are well-recognized complications of cytotoxic chemotherapy and/or radiotherapy. Compared to de novo AML, there is a higher incidence of TP53 mutations, abnormalities of chromosomes 5 or 7, and complex cytogenetics in t-AML. The response to chemotherapy is also reduced compared to de novo AML, and long-term...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
30cb1a24-5c2a-5fc1-b280-65d746a98af7
DOI
10.1182/blood.v122.21.5.5
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AMLDOI 10.1182/blood.v122.21.5.5
Select a neighboring publication to make it the new centre.